Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis

Christopher Geven(Radboud University Nijmegen), Peter Pickkers(Radboud University Nijmegen), Andreas Bergmann(Agostino Gemelli University Polyclinic), Matthijs Kox(Radboud University Medical Center), Mathias Schroedter, Esther Peters(Radboud University Nijmegen), Oscar McCook(University Hospital Ulm), Peter Radermacher(Helmholtz-Institute Ulm), Joachim Struck
Shock
January 12, 2018
Cited by 48


Related Papers